https://qz.com/ozempic-weight-loss-drugs-elon-musk-brazil-red-lobster-1851637050
Viking Therapeutics (VKTX) is one of several pharma companies racing to break up the weight loss drug duopoly currently held by Ozempic-maker Novo Nordisk (NVO) and Eli Lilly (LLY), the producer of Zepbound. Read more…
An Ozempic rival, exploding airplane tires, Elon Musk vs. Brazil: Business news roundup
Published in Business and Uncategorized
More from BusinessMore posts in Business »
- Will bank earnings growth become a thing of the past?
- Chip stocks slide after Broadcom boss warns of ‘casino’ mentality in AI investing
- White House asks US envoy to Greece Kimberly Guilfoyle to resign
- Wall Street plays down investor fears of faltering trading boom
- Crypto exchange MNX takes on OKX, BitGet offering pre-IPO futures for AI giants
- Hachette’s CEO writes every email himself. He says AI shortcuts are creating a ‘worse C-suite’
- UK crypto trader says almost $800,000 lost in knife attack as wrench attacks proliferate
- ‘A very tough market out there’: U.S. home sales fell 2.2% from last year as mortgage rates and prices rise
- JPMorgan, Goldman Sachs, Citigroup and Wells Fargo post strong profits, but warn rising interest rates and ‘sticky inflation’ will bite
- How not to revive Europe’s auto industry
More from UncategorizedMore posts in Uncategorized »
- Will bank earnings growth become a thing of the past?
- Chip stocks slide after Broadcom boss warns of ‘casino’ mentality in AI investing
- White House asks US envoy to Greece Kimberly Guilfoyle to resign
- Wall Street plays down investor fears of faltering trading boom
- Crypto exchange MNX takes on OKX, BitGet offering pre-IPO futures for AI giants
- Hachette’s CEO writes every email himself. He says AI shortcuts are creating a ‘worse C-suite’
- UK crypto trader says almost $800,000 lost in knife attack as wrench attacks proliferate
- ‘A very tough market out there’: U.S. home sales fell 2.2% from last year as mortgage rates and prices rise
- JPMorgan, Goldman Sachs, Citigroup and Wells Fargo post strong profits, but warn rising interest rates and ‘sticky inflation’ will bite
- How not to revive Europe’s auto industry